| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |